Expanding Access to Methadone in Jails & Prisons
Department & Center Events
Presented by the Johns Hopkins Bloomberg Center for Mental Health & Addiction Policy and the White House Office of National Drug Control Policy
Expanding the availability of methadone to more persons who are incarcerated is a key intervention to preventing fentanyl and other opioid related overdose deaths and reducing recidivism. The event will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the 2024 SAMHSA final rule on the use of methadone. It will feature federal policymakers who will discuss recent federal initiatives to increase access to treatment, as well as state and local leaders, and practitioners.
Featured speakers include:
- Rahul Gupta, MD, MPH, FACP, MBA
Director of the White House Office of National Drug Control Policy (ONDCP)
- Brendan Saloner, PhD
Bloomberg Professor of American Health
Johns Hopkins Bloomberg School of Public Health
- Yngvild Olsen, MD, MPH
Director of the Center for Substance Abuse Treatment (CSAT)
Substance Abuse & Mental Health Services Administration (SAMHSA)
- Matthew Strait, MS
Deputy Assistant Administrator, Office of Diversion Control Regulatory (DCR)
Drugs Enforcement Administration (DEA)
- Sara Whaley, MPH, MSW, MA
Senior Practice Associate
Johns Hopkins Bloomberg School of Public Health
- Catherine Smith, DO
Director of Addiction Medicine
Washington State Department of Corrections
- Ryan Thornell, PhD
Director
Arizona Department of Corrections, Rehabilitation and Re-entry
